Cell and gene therapy is entering a new phase of growth and evolution. While early development focused primarily on rare diseases and highly specialized patient populations, the pipeline is expanding into broader indications, earlier lines of therapy and increasingly precise treatment approaches. This webinar will explore the trends shaping these changes and their implications for future access strategies.
As innovation accelerates, stakeholders across the healthcare ecosystem must consider not only what therapies are coming next, but how these developments may affect patient identification, care coordination and access.
The featured speakers will explore key trends shaping the future of the cell and gene therapy landscape, including pipeline expansion, the rise of precision medicine and shifting expectations around patient identification and care coordination.
The featured speakers will discuss how today’s development trends may influence future access models, treatment pathways and commercialization strategies.
Attendees will gain perspective on the opportunities and challenges emerging as cell and gene therapies move toward larger patient populations and more complex care environments.
Register to examine what’s next in the cell and gene therapy pipeline and how emerging trends may shape access, treatment pathways and commercialization planning.
Speakers
Kim Tedesco, RPh, Director of Gene & Cell Therapy Pharmacy Operations, Walgreens Gene & Cell Services
Kim Tedesco, RPh, is the Director of Gene & Cell Therapy Pharmacy Operations at Walgreens Gene & Cell Services Pharmacy. She is a pharmacy leader dedicated to advancing pharmacy practice.
In her current role, Kim leads the strategic direction of the gene and cell pharmacy at Walgreens to create a center of excellence dedicated to gene and cell therapies. She works to overcome barriers and help ensure these new-to-market therapies reach the intended patients.
Kim has previous experience in retail, pharmaceutical sales, operations and specialty pharmacy. She is a licensed Pharmacist in 26 states and attended Duquesne University School of Pharmacy in Pittsburgh, Pennsylvania.
Message Presenter
Dan Powell, PharmD, BCPS, CSP, Patient Solutions Manager & Pharmacist in Charge, Walgreens Gene & Cell Services
Dan Powell, PharmD, BCPS, CSP is the Pharmacist in Charge and Patient Solutions Manager for Walgreens Gene & Cell Services. He brings extensive specialty pharmacy experience in oncology and advanced therapies, including cell and gene therapies. Dr. Powell completed his Acute Care Residency at Allegheny General Hospital after graduation from Ohio Northern University. He is committed to advancing specialty pharmacy practice and improving care and outcomes for patients requiring complex and emerging therapies.
Message PresenterWho Should Attend?
- Cell and Gene Therapy Manufacturers
- Commercialization and Market Access Leaders
- Patient Services and Medical Affairs Professionals
- Provider and Specialty Pharmacy Partners
- Consultants and Advisors Supporting CGT Programs
What You Will Learn
- Key trends shaping the future of the cell and gene therapy (CGT) pipeline
- How expanding indications may affect access and care delivery
- The growing role of precision medicine in patient identification and referral pathways
- What today’s pipeline signals may mean for future commercialization planning
Xtalks Partner
Walgreens
Founded in 1901, Walgreens (www.walgreens.com) proudly serves more than 9 million customers and patients each day across its nearly 8,000 stores throughout the U.S. and Puerto Rico. Walgreens has approximately 211,000 team members, including roughly 85,000 healthcare service providers, and is committed to being the first choice for pharmacy, retail and health services, building trusted relationships that create healthier futures for customers, patients, team members and communities.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account